Package 44567-804-01

Brand: piperacillin and tazobactam

Generic: piperacillin and tazobactam
NDC Package

Package Facts

Identity

Package NDC 44567-804-01
Digits Only 4456780401
Product NDC 44567-804
Description

1 BOTTLE in 1 BOX (44567-804-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2009-10-20
Brand piperacillin and tazobactam
Generic piperacillin and tazobactam
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "9e491f95-a5aa-419e-a39f-159b64db9159", "openfda": {"unii": ["M98T69Q7HP", "UXA545ABTT"], "rxcui": ["312447"], "spl_set_id": ["17a400ae-cbaa-4d07-95f4-c6917dfc0585"], "manufacturer_name": ["WG Critical Care, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 BOX (44567-804-01)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE", "package_ndc": "44567-804-01", "marketing_start_date": "20091020"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "44567-804_9e491f95-a5aa-419e-a39f-159b64db9159", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "44567-804", "generic_name": "Piperacillin and Tazobactam", "labeler_name": "WG Critical Care, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "36 g/1"}, {"name": "TAZOBACTAM SODIUM", "strength": "4.5 g/1"}], "application_number": "ANDA090498", "marketing_category": "ANDA", "marketing_start_date": "20091020", "listing_expiration_date": "20261231"}